Teligent's Distributors Balk At Customer Risks In Ch. 11

By Leslie Pappas (October 15, 2021, 9:33 PM EDT) -- An unexpected lawsuit that emerged earlier this year from Insys Therapeutics Inc.'s bankruptcy case in Delaware raised concerns on Friday among Teligent Inc.'s largest pharmaceutical distributors that the bankrupt generic-drug manufacturer could put their customer programs at risk.

As Teligent kicked off its Chapter 11 bankruptcy at a virtual hearing on Friday, pharmaceutical distributors Cardinal Health, AmerisourceBergen Corp. and McKesson Corp. pushed for assurances that the Iselin, New Jersey-based manufacturer would honor existing customer programs and continue to do business with them as usual.

"They don't have the ability to shut this off at a moment's notice," Cardinal's attorney, Scott Zuber...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!